Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - HUMAN GENOME SCIENCES INC | d339062dex991.htm |
EX-99.2 - EX-99.2 - HUMAN GENOME SCIENCES INC | d339062dex992.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 24, 2012
HUMAN GENOME SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-14169 | 22-3178468 | ||
(State or other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
14200 Shady Grove Road, Rockville, Maryland |
20850-7464 | |||
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (301) 309-8504
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 2 Financial Information
Item 2.02. Results of Operations and Financial Condition.
On April 24, 2012, Human Genome Sciences, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2012. A copy of the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The slide presentation that will be used by management during the conference call to discuss the financial results for the quarter ended March 31, 2012 is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
Section 9 Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 | Press Release, dated April 24, 2012. | |
99.2 | Slide Presentation relating to earnings conference call. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HUMAN GENOME SCIENCES, INC. | ||
By: | /s/ JAMES H. DAVIS, PH.D. | |
Name: | James H. Davis, Ph.D. | |
Title: | Executive Vice President, General Counsel and Secretary |
Date: April 24, 2012
INDEX TO EXHIBITS
Exhibit No. |
Description | |
99.1 | Press Release, dated April 24, 2012. | |
99.2 | Slide Presentation relating to earnings conference call. |